Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A04312 | Pages: 207 | Charts: 45 | Tables: 89 |
The global sleep apnea diagnostics market was valued at $290.50 million in 2020, and is projected to reach $545.09 million by 2030, registering a CAGR of 6.7% from 2021 to 2030.
[COVIDIMPACTSTATEMENT]
Sleep apnea is a sleeping disorder that can lead to serious health problems, including hypertension (high blood pressure), stroke, cardiomyopathy (enlargement of the muscle tissue of the heart), heart failure, diabetes and heart attacks. Untreated sleep apnea causes breathing to stop repeatedly during sleep, causing loud snoring and daytime tiredness, even with a full night’s sleep. Sleep apnea can affect anyone, but most often older men who are overweight. Sleep apnea occurs in about 25% of men and nearly 10% of women. It can affect people of all ages, including babies and children and particularly people over the age of 50 and those who are overweight. Certain physical traits and clinical features are common in patients with obstructive sleep apnea. These include excessive weight, large neck, and structural abnormalities reducing the diameter of the upper airway, such as nasal obstruction, a low-hanging soft palate, enlarged tonsils, or a small jaw with an overbite. Sleep apnea is caused by a blockage of the airway, usually when the soft tissue in the rear of the throat collapses during sleep. The diagnosis of this includes the sleep test like overnight sleep study called a polysomnogram (PSG) and a home sleep test (HST).
Get more information on this report : Request Sample Pages
The growth of the global sleep apnea diagnostics market is driven by significant increase in the incidence of sedentary lifestyle disorders, including obesity, diabetes, and hypertension, working in shifts & stressful working environments cause sleep apnea, and various technological advancements in sleep apnea diagnostics devices. However, high cost of sleep apnea diagnostics and lack of awareness about the sleep apnea pose to restrain the growth of the sleep apnea diagnostics market. Conversely, untapped markets of developing economies are expected to offer lucrative opportunities during the forecast period.
Coronavirus (COVID-19) was discovered in late December in Hubei province of Wuhan city in China. The disease is caused by a virus, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted among humans. supply chains were disrupted due to restrictions on trade of pharmaceutical ingredients and products across countries. In addition, COVID 19 is an infectious disease with flu-like symptoms, including fever, cough, and difficulty in breathing. In its disruption to clinical trials and drug supply to patients, the COVID-19 pandemic has impacted the most crucial areas of the sleep apnea diagnostics market. The banned trade with other nations and enforced travel restrictions, resulting in decline in diagnostics and surgical procedures in the first half of 2020. According to the study published in the British Journal of Surgery, around 28.4 million elective procedures were cancelled or postponed in May 2020, based on a 12-week period of peak disruption to hospital services due to COVID-19. There has been a significant reduction in hospitals and sleep laboratory-based diagnosis of sleep apnea.
The global sleep apnea diagnostics market is segmented into product, end user, and region. Depending on product, the market is fragmented into polysomnography (PSG) devices, actigraphy systems, respiratory polygraph, sleep apnea screening device, oximeter. On the basis of end user, it is bifurcated into hospital & sleep lab and homecare. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By product, the polysomnography device (PSG) segment was the major revenue contributor in 2020, and is expected to maintain this dominance throughout the forecast period. This is attributed to the wide use of PSG devices in hospitals & sleep labs, as PSG enables the doctor to monitor varied parameters of sleep apnea, such as brain activity, muscle activity, and breathing activity to get a comprehensive interpretation of what disorder the patient is suffering from.
[PRODUCTGRAPH]
Get more information on this report : Request Sample Pages
On the basis of end user, the market is divided into hospital & sleep lab and homecare. The hospital & sleep lab segment dominates the global sleep apnea diagnostics market, owing to the preference among patients to visit hospitals for the diagnosis of sleep apnea. In addition, sleep labs possess different equipment and medical settings required to monitor sleep apnea.
[ENDUSERGRAPH]
Get more information on this report : Request Sample Pages
North America accounted for the highest market share in 2020, due to availability of advance therapeutics, higher spreading of awareness, and heavy expenditure by the government on healthcare, followed by Europe and Asia-Pacific. Pharmaceutical companies have focused on expanding their presence in emerging economies, which is anticipated to drive the market growth.
[REGIONGRAPH]
Get more information on this report : Request Sample Pages
Sleep Apnea Diagnostics Market Research Study Key Benefits:
Key Market Segments
Key Market Players
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.2.3.Top winning strategies, by year, 2019-2021
3.2.4.Top winning strategies, by developments, 2019-2021(%).
3.2.5.Top winning strategies, by company, 2019-2021.
3.2.6.Top player positioning, 2020
3.3.Porter’s five force analysis
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Rise in prevalence of obesity across the globe
3.4.1.2.Increase in number of employees working in shifts and under stressful work conditions
3.4.1.3.Technological advancements in sleep apnea diagnostic devices
3.4.2.Restraints
3.4.2.1.High cost associated with sleep apnea diagnostic devices
3.4.2.2.Lack of awareness among patients regarding sleep apnea
3.4.3.Opportunity
3.4.3.1.Untapped markets in developing economies
3.5.COVID-19 impact analysis on sleep apnea diagnostics market
CHAPTER 4:SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Polysomnography device (PSG)
4.2.1.Key trends and opportunities
4.2.2.List of distributors
4.2.3.Market size and forecast, by region
4.2.4.Market analysis, by country
4.2.5.Clinical PSG
4.2.5.1.1.Market size and forecast
4.2.6.Ambulatory PSG
4.2.6.1.1.Market size and forecast
4.3.Sleep apnea screening device
4.3.1.Key trends and opportunities
4.3.2.List of ditributors
4.3.3.Market size and forecast
4.3.4.Market analysis, by country
4.4.Actigraphy monitoring device
4.4.1.Key trends and opportunities
4.4.2.List of distributors
4.4.3.Market size and forecast
4.4.4.Market analysis, by country
4.5.Respiratory polygraph
4.5.1.Key trends and opportunities
4.5.2.List of distributors
4.5.3.Market size and forecast
4.5.4.Market analysis, by country
4.6.Oximeter
4.6.1.Key trends and opportunities
4.6.2.List of distributors
4.6.3.Market size and forecast, by region
4.6.4.Market analysis, by country
4.6.5.Fingertip oximeter
4.6.5.1.1.Market size and forecast
4.6.6.Handheld oximeter
4.6.6.1.1.Market size and forecast
4.6.7.Wrist-worn oximeter
4.6.7.1.1.Market size and forecast
4.6.8.Tabletop oximeter
4.6.8.1.1.Market size and forecast
CHAPTER 5:SLEEP APNEA DIAGNOSTICS MARKET, BY END USER
5.1.Overview
5.1.1.Market size and forecast
5.2.Hospitals & sleep laboratories
5.2.1.List of distributors
5.2.2.Market size and forecast
5.2.3.Market analysis, by country
5.3.Home care settings
5.3.1.List of distributors
5.3.2.Market size and forecast
5.3.3.Market analysis, by country
CHAPTER 6:SLEEP APNEA DIAGNOSTICS MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast
6.2.North America
6.2.1.Key trends and opportunities
6.2.2.List of distributors
6.2.3.North America market size and forecast, by country
6.2.3.1.U.S. market size and forecast, by product
6.2.3.2.U.S. market size and forecast, by end user
6.2.3.3.Canada market size and forecast, by product
6.2.3.4.Canada market size and forecast, by end user
6.2.3.5.Mexico market size and forecast, by product
6.2.3.6.Mexico market size and forecast, by end user
6.2.4.North America market size and forecast, by product
6.2.5.North America market size and forecast, by end user
6.3.Europe
6.3.1.Key trends and opportunities
6.3.2.List of distributors
6.3.3.Europe market size and forecast, by country
6.3.3.1.Germany market size and forecast, by product
6.3.3.2.Germany market size and forecast, by end user
6.3.3.3.UK market size and forecast, by product
6.3.3.4.UK market size and forecast, by end user
6.3.3.5.France market size and forecast, by product
6.3.3.6.France market size and forecast, by end user
6.3.3.7.Italy market size and forecast, by product
6.3.3.8.Italy market size and forecast, by end user
6.3.3.9.Spain market size and forecast, by product
6.3.3.10.Spain market size and forecast, by end user
6.3.3.11.Rest of Europe market size and forecast, by Product
6.3.3.12.Rest of Europe market size and forecast, by end user
6.3.4.Europe market size and forecast, by product
6.3.5.Europe market size and forecast, by end user
6.4.Asia-Pacific
6.4.1.Key trends and opportunities
6.4.2.List of distributors
6.4.3.Asia-Pacific market size and forecast, by country
6.4.3.1.Japan market size and forecast, by product
6.4.3.2.Japan market size and forecast, by end user
6.4.3.3.China market size and forecast, by product
6.4.3.4.China market size and forecast, by end user
6.4.3.5.Australia market size and forecast, by product
6.4.3.6.Australia market size and forecast, by end user
6.4.3.7.India market size and forecast, by product
6.4.3.8.India market size and forecast, by end user
6.4.3.9.Rest of Asia-Pacific market size and forecast, by product
6.4.3.10.Rest of Asia-Pacific market size and forecast, by end user
6.4.4.Asia-Pacific market size and forecast, by product
6.4.5.Asia-Pacific market size and forecast, by end user
6.5.LAMEA
6.5.1.Key market trends and opportunities
6.5.2.List of distributors
6.5.3.LAMEA market size and forecast, by country
6.5.3.1.Brazil market size and forecast, by product
6.5.3.2.Brazil market size and forecast, by end user
6.5.3.3.South Africa market size and forecast, by product
6.5.3.4.South Africa market size and forecast, by end user
6.5.3.5.Saudi Arabia market size and forecast, by product
6.5.3.6.Saudi Arabia market size and forecast, by end user
6.5.3.7.Rest of LAMEA market size and forecast, by product
6.5.3.8.Rest of LAMEA market size and forecast, by end user
6.5.4.LAMEA market size and forecast, by product
6.5.5.LAMEA market size and forecast, by end user
CHAPTER 7:COMPANY PROFILES
7.1.Cadwell Industries Inc.
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance
7.1.6.Key strategic moves and developments
7.2.Devilbiss Healthcare
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.3.Koninklijke Philips N.V. (Philips)
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.4.Medtronic Plc.
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segment
7.4.4.Product portfolio
7.4.5.Business performance
7.5.Mindray Medical International Limited
7.5.1.Company overview
7.5.2.Operating business segment
7.5.3.Product portfolio
7.6.Natus Medical Incorporated
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance
7.7.Nihon Kohden Corporation
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.7.5.Business performance
7.8.Resmed Inc.
7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segment
7.8.4.Product portfolio
7.8.5.Business performance
7.8.6.Key strategic moves and developments
7.9.Smith’s Group Plc. (Smiths Medical)
7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance
7.10.SOMNOmedics Gmbh
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Business performance
LIST OF TABLES
TABLE 01.GLOBAL SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 02.SLEEP APNEA DIAGNOSTICS MARKET FOR POLYSOMNOGRAPHY DEVICE (PSG) BY REGION, 2020-2030($MILLION)
TABLE 03.SLEEP APNEA DIAGNOSTICS MARKET FOR SLEEP APNEA SCREENING DEVICE, BY REGION, 2020-2030($MILLION)
TABLE 04.SLEEP APNEA DIAGNOSTICS MARKET FOR ACTIGRAPHY MONITORING DEVICE, BY REGION, 2020-2030($MILLION)
TABLE 05.SLEEP APNEA DIAGNOSTICS MARKET FOR RESPIRATORY POLYGRAPHS, BY REGION, 2020-2030($MILLION)
TABLE 06.SLEEP APNEA DIAGNOSTICS MARKET FOR OXIMETER, BY REGION, 2020-2030($MILLION)
TABLE 07.GLOBAL SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 08.SLEEP APNEA DIAGNOSTICS MARKET FOR HOSPITALS & SLEEP LABORATORIES, BY REGION, 2020-2030 ($MILLION)
TABLE 09.SLEEP APNEA DIAGNOSTICS MARKET FOR HOME CARE SETTINGS, BY REGION, 2020-2030 ($MILLION)
TABLE 10.SLEEP APNEA DIAGNOSTICS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 11.NORTH AMERICA SLEEP APNEA DIAGNOSTICS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 12.U.S. SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 13.U.S. SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 14.CANADA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 15.CANADA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 16.MEXICO. SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 17.MEXICO SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 18.NORTH AMERICA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 19.NORTH AMERICA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 20.EUROPE SLEEP APNEA DIAGNOSTICS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 21.GERMANY SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 22.GERMANY SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 23.UK SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 24.UK SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 25.FRANCE SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 26.FRANCE SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 27.ITALY SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 28.ITALY SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 29.SPAIN SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 30.SPAIN SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 31.REST OF EUROPE SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 32.REST OF EUROPE SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 33.EUROPE SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 34.EUROPE SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 35.ASIA-PACIFIC SLEEP APNEA DIAGNOSTICS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 36.JAPAN SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 37.JAPAN SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 38.CHINA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 39.CHINA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 40.AUSTRALIA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 41.AUSTRALIA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 42.INDIA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 43.INDIA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 44.REST OF ASIA-PACIFIC SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 45.REST OF ASIA-PACIFIC SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 46.ASIA-PACIFIC SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 47.ASIA-PACIFIC SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 48.LAMEA ALLERY END USER MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 49.BRAZIL SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 50.BRAZIL SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 51.SOUTH AFRICA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 52.SOUTH AFRICA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 53.SAUDI ARABIA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 54.SAUDI ARABIA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 55.REST OF LAMEA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 56.REST OF LAMEA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 57.LAMEA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 58.LAMEA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 59.CADWELL: COMPANY SNAPSHOT
TABLE 60.CADWELL: OPERATING SEGMENTS
TABLE 61.CADWELL: PRODUCT PORTFOLIO
TABLE 62.CADWELL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 63.DEVILBISS: COMPANY SNAPSHOT
TABLE 64.DEVILBISS: PRODUCT PORTFOLIO
TABLE 65.PHILIPS: COMPANY SNAPSHOT
TABLE 66.PHILIPS: OPERATING SEGMENTS
TABLE 67.PHILIPS: PRODUCT PORTFOLIO
TABLE 68.MEDTRONIC: COMPANY SNAPSHOT
TABLE 69.MEDTRONIC: OPERATING SEGMENT
TABLE 70.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 71.MINDRAY: COMPANY SNAPSHOT
TABLE 72.MINDRAY: OPERATING SEGMENTS
TABLE 73.MINDRAY: PRODUCT PORTFOLIO
TABLE 74.NATUS: COMPANY SNAPSHOT
TABLE 75.NATUS: OPERATING SEGMENTS
TABLE 76.NATUS: PRODUCT PORTFOLIO
TABLE 77.NIHON KOHDEN: COMPANY SNAPSHOT
TABLE 78.NIHON KOHDEN: OPERATING SEGMENTS
TABLE 79.NIHON: PRODUCT PORTFOLIO
TABLE 80.RESMED: COMPANY SNAPSHOT
TABLE 81.RESMED: OPERATING SEGMENTS
TABLE 82.RESMED: PRODUCT PORTFOLIO
TABLE 83.RESMED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 84.SMITHS: COMPANY SNAPSHOT
TABLE 85.SMITHS: OPERATING SEGMENTS
TABLE 86.SMITHS: PRODUCT PORTFOLIO
TABLE 87.SOMNOMEDICS: COMPANY SNAPSHOT
TABLE 88.SOMNOMEDICS: OPERATING SEGMENTS
TABLE 89.SOMNOMEDICS: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.GLOBAL SLEEP APNEA DIAGNOSTIC DEVICES MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP PLAYER POSITIONING, 2020
FIGURE 04.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 05.MODERATE BARGAINING POWER OF BUYERS
FIGURE 06.MODERATE THREAT OF SUBSTITUTES
FIGURE 07.MODERATE THREAT OF NEW ENTRANTS
FIGURE 08.MODERATE INTENSITY OF RIVALRY
FIGURE 09.GLOBAL SLEEP APNEA DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 10.COMPARATIVE SHARE ANALYSIS OF SLEEP APNEA DIAGNOSTICS MARKET FOR POLYSOMNOGRAPHY DEVICE (PSG) BY COUNTRY, 2020 & 2030 (%)
FIGURE 11.GLOBAL SLEEP APNEA DIAGNOSTICS MARKET FOR CLINICAL POLYSOMNOGRAPHY DEVICE (PSG), 2020-2030($MILLION)
FIGURE 12.GLOBAL SLEEP APNEA DIAGNOSTICS MARKET FOR AMBULATORY POLYSOMNOGRAPHY DEVICE (PSG), 2020-2030($MILLION)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF SLEEP APNEA DIAGNOSTICS MARKET FOR SLEEP APNEA SCREENING DEVICE, BY COUNTRY, 2020 & 2030 (%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF SLEEP APNEA DIAGNOSTICS MARKET FOR ACTIGRAPHY MONITORING DEVICE, BY COUNTRY, 2020 & 2030 (%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF OTHER SLEEP APNEA DIAGNOSTICS MARKET FOR RESPIRATORY POLYGRAPH, BY COUNTRY, 2020 & 2030 (%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF SLEEP APNEA DIAGNOSTICS MARKET FOR OXIMETER, BY COUNTRY, 2020 & 2030 (%)
FIGURE 17.GLOBAL SLEEP APNEA DIAGNOSTICS MARKET FOR FINGERTIP OXIMETER DEVICE, 2020-2030($MILLION)
FIGURE 18.GLOBAL SLEEP APNEA DIAGNOSTICS MARKET FOR HANDHELD OXIMETER DEVICE, 2020-2030($MILLION)
FIGURE 19.GLOBAL SLEEP APNEA DIAGNOSTICS MARKET FOR WRIST-WORN OXIMETER DEVICE, 2020-2030($MILLION)
FIGURE 20.GLOBAL SLEEP APNEA DIAGNOSTICS MARKET FOR TABLETOP OXIMETER DEVICE, 2020-2030($MILLION)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF SLEEP APNEA DIAGNOSTICS MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2020 & 2030 (%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF SLEEP APNEA DIAGNOSTICS MARKET FOR HOME CARE SETTINGS, BY COUNTRY 2020 & 2030 (%)
FIGURE 23.CADWELL: NET SALES, 2018–2020 ($MILLION)
FIGURE 24.CADWELL: REVENUE SHARE BY REGION, 2020(%)
FIGURE 25.PHILIPS: NET SALES, 2018–2020 ($MILLION)
FIGURE 26.PHILIPS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 27.PHILIPS: REVENUE SHARE BY REGION, 2020(%)
FIGURE 28.MEDTRONIC: NET SALES, 2020 ($MILLION)
FIGURE 29.MEDTRONIC: REVENUE SHARE PER SEGMENT 2020(%)
FIGURE 30.MEDTRONIC: REVENUE SHARE BY REGION, 2020(%)
FIGURE 31.NATUS: NET SALES, 2020 ($MILLION)
FIGURE 32.NATUS: REVENUE SHARE BY PRODUCT, 2020 (%)
FIGURE 33.NATUS: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 34.NIHON KOHDEN: NET SALES, 2018-2020 ($MILLION)
FIGURE 35.NIHON KOHDEN: REVENUE SHARE BY SEGMENT, 2020(%)
FIGURE 36.NIHON KOHDEN: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 37.RESMED: NET SALES, 2019–2020 ($MILLION)
FIGURE 38.RESMED: REVENUE SHARE BY SEGMENT, 2020 ($MILLION)
FIGURE 39.RESMED: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 40.SMITHS: NET SALES, 2018–2020 ($MILLION)
FIGURE 41.SMITHS: REVENUE SHARE BY DIVISION, 2020 (%)
FIGURE 42.SMITHS: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 43.SOMNOMEDICS: NET SALES, 2018–2020 ($MILLION)
FIGURE 44.SOMNOMEDICS: REVENUE SHARE BY DIVISION, 2020 (%)
FIGURE 45.SOMNOMEDICS: REVENUE SHARE BY REGION, 2020 (%)